rs3736830
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002267.4(KPNA3):c.383+286C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.726 in 151,992 control chromosomes in the GnomAD database, including 41,370 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.73 ( 41370 hom., cov: 31)
Consequence
KPNA3
NM_002267.4 intron
NM_002267.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.303
Publications
16 publications found
Genes affected
KPNA3 (HGNC:6396): (karyopherin subunit alpha 3) The transport of molecules between the nucleus and the cytoplasm in eukaryotic cells is mediated by the nuclear pore complex (NPC), which consists of 60-100 proteins. Small molecules (up to 70 kD) can pass through the nuclear pore by nonselective diffusion while larger molecules are transported by an active process. The protein encoded by this gene belongs to the importin alpha family, and is involved in nuclear protein import. [provided by RefSeq, Jan 2009]
KPNA3 Gene-Disease associations (from GenCC):
- spastic paraplegia 88, autosomal dominantInheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.835 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KPNA3 | ENST00000261667.8 | c.383+286C>G | intron_variant | Intron 6 of 16 | 1 | NM_002267.4 | ENSP00000261667.3 |
Frequencies
GnomAD3 genomes AF: 0.726 AC: 110258AN: 151876Hom.: 41347 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
110258
AN:
151876
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.726 AC: 110325AN: 151992Hom.: 41370 Cov.: 31 AF XY: 0.721 AC XY: 53584AN XY: 74282 show subpopulations
GnomAD4 genome
AF:
AC:
110325
AN:
151992
Hom.:
Cov.:
31
AF XY:
AC XY:
53584
AN XY:
74282
show subpopulations
African (AFR)
AF:
AC:
22983
AN:
41392
American (AMR)
AF:
AC:
11160
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
2477
AN:
3470
East Asian (EAS)
AF:
AC:
2155
AN:
5188
South Asian (SAS)
AF:
AC:
3804
AN:
4820
European-Finnish (FIN)
AF:
AC:
7971
AN:
10544
Middle Eastern (MID)
AF:
AC:
217
AN:
294
European-Non Finnish (NFE)
AF:
AC:
57127
AN:
67972
Other (OTH)
AF:
AC:
1542
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1418
2836
4254
5672
7090
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
832
1664
2496
3328
4160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2196
AN:
3474
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.